Richard Pestell Md serves as Executive at CytoDyn Inc., where they oversee executive responsibilities. Since joining the company, Richard Pestell Md has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 16, 2018 involved receiving (via award) 12,782,440 shares valued at $7.3M.
Richard Pestell Md currently holds 21,124,440 shares of CytoDyn Inc. (CYDY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Pestell Md has been a net neutral trader of CYDY stock. They have purchased $0 and sold $0 worth of shares.
Richard Pestell Md's most recent insider trade was on Nov 16, 2018, when they sold 12,782,440 shares at $0.57 per share.
Get notified when new Form 4 filings are submitted
| $0.57 |
| Discretionary |